Advertisement

Cytotoxic extravasation: an issue disappearing or a problem without solution?

Abstract

Purpose

The incidence and management of antitumoral compound extravasation that occurred in our medical day hospital unit were registered in a 10-year period.

Methods

A total of 114 episodes were consecutively recorded out of an estimated number of 211,948 administrations performed (0.05%). Type of compound, localization, timing, symptoms, treatment, resolution, or sequelae were documented.

Results

Extravasations after anthracyclines (17/114), platinum compounds (34/114), vinca alkaloids (7/114), and taxanes (34/114) were more frequently associated with edema and erythema ± pain. Five cases of monoclonal antibodies extravasation were observed without sequelae. With the involvement of an interdisciplinary task force and the use of dedicated guidelines, conservative management was successful in all patients. In the great majority of cases, recovery was complete within 48 hours after antidote administration. The support of our pharmacy was crucial. Physiatric evaluation was considered in several cases. No patients required surgery.

Conclusions

We confirm that the adopted standardized approach to this event resulted in a satisfactory outcome and could be suggested as appropriate for managing extravasation in a large clinical context.

Tumori 2016; 102(3): 290 - 293

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/tj.5000486

Authors

Laura A.M. Ferrari, Gabriella L. Dinoi, Gabriella Saibene, Barbara Re, Augusta Balzarini, Lucia Giordano, Elena Sala, Cristina Bregant

Article History

Disclosures

Financial support: No financial support was received for this submission.
Conflict of interest: None of the authors has conflict of interest with this submission.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  •  SCDHM/Outpatient Therapy Oncology, Foundation IRCCS National Cancer Institute, Milan - Italy
  •  SC Pharmacy, Foundation IRCCS National Cancer Institute, Milan - Italy
  •  SC Palliative Care, Foundation IRCCS National Cancer Institute, Milan - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.